Document is current
Any future updates will be listed below
-
Authors
Jacobs, Jonathan P.
Goudarzi, Maryam
Lagishetty, Venu
Li, Dalin
Mak, Tytus
Tong, Maomeng
Ruegger, Paul
Haritunians, Talin
Landers, Carol
Fleshner, Philip
Vasiliauskas, Eric
Ippoliti, Andrew
Melmed, Gil
Shih, David
Targan, Stephan
Borneman, James
Fornace, Albert J. Jr
McGovern, Dermot P. B.
Braun, Jonathan http://orcid.org/0000-0003-1646-2974
-
Funding
Funding for this research was provided by:
Crohn's and Colitis Foundation of America
USPHS (PO1DK046763)
National Center for Advancing Translational Sciences (UL1TR000124)
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK07180, DK062413, DK046763)
U.S. Department of Veterans Affairs (IK2CX001717)
National Institute of Allergy and Infectious Diseases (AI067068)
- License Information
-
More Information
Article History
Received: 13 January 2022
Accepted: 2 August 2022
First Online: 15 August 2022
Declarations
:
: The Cedars-Sinai Medical Center Institutional Review Board approved the protocols governing participants (IRB #3358). All subjects provided informed consent to participate in this study. The research conformed to the principles of the Helsinki Declaration.
: Not applicable.
: Cedars-Sinai Medical Center, Dr. Stephan Targan, and Dr. Dermot McGovern have financial interests in Prometheus Biosciences, Inc., a company which has access to the data and specimens in Cedars-Sinai’s MIRIAD Biobank (including the data and specimens used in this study). Prometheus Biosciences seeks to develop commercial products. The remaining authors declare that they have no competing interests.
